Skip to main content

WRIB 2026

The Workshops on Recent Issues in Bioanalysis (WRIB) is one of the most influential global meetings focused on bioanalysis, biomarkers, immunogenicity, gene and cell therapy, and vaccines. Taking place April 13–17, 2026 in Dallas, TX, USA, the conference brings together pharmaceutical and biotechnology companies, CROs, and regulatory agencies to explore emerging scientific challenges, regulatory expectations, and evolving technologies shaping the future of bioanalysis.

Building on the success of the previous meeting, which brought together more than 1,200 professionals worldwide, WRIB continues to emphasize scientific excellence, regulatory insight, and practical solutions for advancing bioanalytical science.


Event Details

📅 April 13–17, 2026
📍 Dallas, TX, USA

Visit Eurofins Clinical Trial Solutions at Booth 49

REQUEST A MEETING


Meet Eurofins Clinical Trial Solutions at WRIB

Connect with the Eurofins Clinical Trial Solutions team at Booth 49 to learn how our global bioanalytical capabilities support complex clinical development programs.

Our scientific teams provide expertise across:

  • LC-MS bioanalysis

  • Ligand-binding assays

  • Biomarker testing

  • Immunogenicity assessments

  • Support for gene and cell therapy programs

By combining scientific expertise with regulatory experience and operational excellence, we help sponsors generate reliable bioanalytical data that supports confident decision-making throughout drug development.

Schedule time with our experts to discuss upcoming studies, scientific challenges, and strategies to advance your bioanalytical programs.


Scientific Poster Presentation

Eurofins Clinical Trial Solutions is proud to share that Mark Wissel, Director of R&D, will be presenting a scientific poster at WRIB 2026.

Poster Title:
Harmonizing qPCR and dPCR readouts for standardized analytical use: copies/µL reporting, negative control–anchored thresholding, and multiplex clarity

This research explores approaches to improve consistency and interpretability between qPCR and digital PCR (dPCR) readouts, helping enable more standardized analytical applications in bioanalysis.

Presentation date and time will be announced soon.

Visit our team at Booth 49 to learn more about this work and discuss how these approaches may support your bioanalytical programs.


Our Team Attending WRIB

The following Eurofins Clinical Trial Solutions experts will be attending WRIB and available to discuss your bioanalytical needs:

  • Jason Neat, President
  • Mark Wissel, PhD, Director, R&D
  • Corey Ohnmacht, PhD, Director, Bioanalytical Services (LC-MS)
  • John Holtzclaw, Scientific Advisor
  • James Furbee, Director of Business Development
  • Danielle Medeiros, Director of Business Development
  • Jennifer Absher, Director of Marketing

Schedule a Meeting

Attending WRIB? Connect with the Eurofins Clinical Trial Solutions team onsite to discuss your upcoming studies and bioanalytical strategy.

REQUEST A MEETING

Back to top